Exicure, Inc. (XCUR)
1.08
+0.02
(+1.89%)
USD |
NASDAQ |
Nov 13, 16:00
1.05
-0.03
(-2.78%)
After-Hours: 19:59
Exicure Enterprise Value : 5.167M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 5.167M |
| November 12, 2026 | 5.039M |
| November 11, 2026 | 5.358M |
| November 10, 2026 | 5.167M |
| November 09, 2026 | 3.958M |
| November 06, 2026 | 4.337M |
| November 05, 2026 | 3.956M |
| November 04, 2026 | 4.611M |
| November 03, 2026 | 4.721M |
| November 02, 2026 | 4.784M |
| October 30, 2026 | 4.721M |
| October 29, 2026 | 4.241M |
| October 28, 2026 | 4.762M |
| October 27, 2026 | 5.103M |
| October 26, 2026 | 5.231M |
| October 23, 2026 | 4.976M |
| October 22, 2026 | 5.486M |
| October 21, 2026 | 4.721M |
| October 20, 2026 | 4.649M |
| October 19, 2026 | 4.848M |
| October 16, 2026 | 5.422M |
| October 15, 2026 | 5.422M |
| October 14, 2026 | 5.995M |
| October 13, 2026 | 5.613M |
| October 12, 2026 | 5.231M |
| Date | Value |
|---|---|
| October 09, 2026 | 4.976M |
| October 08, 2026 | 4.657M |
| October 07, 2026 | 4.784M |
| October 06, 2026 | 5.167M |
| October 05, 2026 | 5.103M |
| October 02, 2026 | 5.613M |
| October 01, 2026 | 5.804M |
| September 30, 2026 | 5.867M |
| September 29, 2026 | 5.549M |
| September 28, 2026 | 6.155M |
| September 25, 2026 | 6.059M |
| September 24, 2026 | 6.123M |
| September 23, 2026 | 6.187M |
| September 22, 2026 | 6.505M |
| September 21, 2026 | 6.314M |
| September 18, 2026 | 6.123M |
| September 17, 2026 | 6.888M |
| September 16, 2026 | 6.760M |
| September 15, 2026 | 6.633M |
| September 14, 2026 | 7.015M |
| September 11, 2026 | 7.206M |
| September 10, 2026 | 7.015M |
| September 09, 2026 | 7.398M |
| September 08, 2026 | 7.270M |
| September 04, 2026 | 6.250M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -39.96M |
| Century Therapeutics, Inc. | 219.34M |
| Absci Corp. | 1.286B |
| Celularity, Inc. | 87.70M |
| Cardio Diagnostics Holdings, Inc. | 1.890M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.121M |
| Total Expenses (Quarterly) | 1.121M |
| EPS Diluted (Quarterly) | -0.1759 |
| Earnings Yield | -120.6% |
| Normalized Earnings Yield | -106.96 |